Skip to main content

Lipid changes associated with antiretroviral therapy: results differ by reporting approach.

Publication ,  Journal Article
Lakey, W; Hicks, C
Published in: Curr HIV Res
September 2009

In order to evaluate consistency and comparability of lipid reporting in antiretroviral treatment (ART) studies, 25 ART trials cited in the Department of Health and Human Services Guidelines were analyzed. Changes in lipids from a separate clinical cohort initiating ART were presented using different approaches to illustrate impact of various methods. Most trials presented lipids as the proportion of graded laboratory toxicities (n=20). Studies of protease inhibitor (PI)-based regimens reported lipids more completely than non-nucleoside reverse transcriptase inhibitor (NNRTI)-based studies. Trials comparing PI-based regimens to NNRTI therapy generally reported graded toxicities or did not include lipids. Within the cohort group, lipid changes appeared lower when presented as median values compared to mean values. Use of grade 3 or higher lipid elevations as the reporting method minimized impact: only 1/64 (2%) reached this threshold. In contrast, reporting outcomes as proportion not at goal per National Cholesterol Education Program (NCEP) Guidelines revealed rates of 23% for triglycerides and 39% for HDL cholesterol. The Framingham risk-prediction model predicted an elevated 10 year risk of cardiovascular disease in 12%. Lipid reporting approaches vary considerably among published ART trials. Implementing a standard approach to reporting lipids including use of NCEP Guidelines and the Framingham risk-prediction model may provide more useful data for clinicians.

Duke Scholars

Published In

Curr HIV Res

DOI

EISSN

1873-4251

Publication Date

September 2009

Volume

7

Issue

5

Start / End Page

547 / 554

Location

Netherlands

Related Subject Headings

  • Virology
  • Triglycerides
  • Middle Aged
  • Male
  • Lipid Metabolism
  • Humans
  • HIV Infections
  • Female
  • Clinical Trials as Topic
  • Cholesterol, HDL
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lakey, W., & Hicks, C. (2009). Lipid changes associated with antiretroviral therapy: results differ by reporting approach. Curr HIV Res, 7(5), 547–554. https://doi.org/10.2174/157016209789346318
Lakey, Wanda, and Charles Hicks. “Lipid changes associated with antiretroviral therapy: results differ by reporting approach.Curr HIV Res 7, no. 5 (September 2009): 547–54. https://doi.org/10.2174/157016209789346318.
Lakey, Wanda, and Charles Hicks. “Lipid changes associated with antiretroviral therapy: results differ by reporting approach.Curr HIV Res, vol. 7, no. 5, Sept. 2009, pp. 547–54. Pubmed, doi:10.2174/157016209789346318.

Published In

Curr HIV Res

DOI

EISSN

1873-4251

Publication Date

September 2009

Volume

7

Issue

5

Start / End Page

547 / 554

Location

Netherlands

Related Subject Headings

  • Virology
  • Triglycerides
  • Middle Aged
  • Male
  • Lipid Metabolism
  • Humans
  • HIV Infections
  • Female
  • Clinical Trials as Topic
  • Cholesterol, HDL